new glp 1 medications Retatrutide for weight loss: Study shows 30% body weight loss Swiss Re says GLP-1 drugs
Description
Aviles-Olmos I, Limousin P, Lees A, Foltynie T
Of these, 63 articles were excluded based on various reasons, as demonstrated in Supplementary Material 2
The upcoming SURMOUNT-MAINTAIN trial, expected to report results around mid-2026, will specifically compare the 5 mg maintenance dose against higher doses for weight maintenance after initial loss
doi:10.1111/jnc.13248 33
GLP-1RA, glucagon-like peptide-1 receptor agonist
